… oral anticoagulant treatment for elderly patients with NVAF. … and effectiveness of rivaroxaban
in Japanese patients with NVAF … events, suggesting that rivaroxaban is safe and effective for …

… ) of rivaroxaban in Japanese patients with AF who received a 15 mg od dose of rivaroxaban
… : 3,243.04 μg*h/L), in Caucasian patients with AF who received a 20 mg od dose (Tanigawa …

… with deep vein Thrombosis and puLmonarY embolism), we aimed to investigate the effectiveness
and safety of rivaroxaban in Japanese patients with VTE in a real-world setting.In …

… The findings of this study in Japanese patients with acute DVT and/or PE suggest a similar
efficacy and safety profile with rivaroxaban and control treatment, consistent with that of the …

… In the present study, all 5 patients with ICH during rivaroxaban treatment had a HAS-BLED …
that patients at high risk of bleeding are also at high risk of ICH during rivaroxaban treatment. …

… following rivaroxaban treatment for Japanese NVAF patients in real-world clinical practice. …
who had adverse events, such as major bleeding after beginning rivaroxaban treatment may …

… that rivaroxaban was non-inferior to dose-adjusted warfarin in Japanese patients for principal
… ratios of MB and NMCRB in the warfarin treatment group were different compared with the …

… patients enrolled in the J’xactly study received under-dosing of rivaroxaban for the initial
treatment… clinical implications of rivaroxaban under-dosing among Japanese patients with VTE. …

… (rivaroxaban) for clinical use in Japanese patients with venous thromboembolism (VTE).
This study will provide important information on the use of rivaroxaban in Japanese patients …

… In Japan, however, old Japanese patients (age >70 years) receiving anticoagulant therapy
may require lower therapeutic ranges than Westerners [international normalized ratio (INR) …